Galveston County Daily News, June 29, 2008 UTMB's Dr. Orhan Ozkan, the principal investigator in this clinical trial, is quoted as saying a new drug delivery system to treat metastases from malignant melanoma allows physicians to deliver significantly higher amounts of anti-cancer drugs directly to a diseased area. UTMB will be the only place where the treatment will be available in a region that includes Texas.